News
- RIT/
- Viral Genetics Lab/
- News
-
February 23, 2023
Funding for RIT research tops $92 million
Rochester Beacon highlights RIT’s research portfolio.
-
August 4, 2022
Monkeypox vaccines: A virologist answers 6 questions about how they work, who can get them and how well they prevent infection
The Conversation asks Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about the two vaccines that can protect against monkeypox.
-
March 28, 2022
RIT scientist receives NIH grant to study viruses with potential to treat prostate cancer
The National Institutes of Health are funding RIT scientists to explore vesicular stomatitis virus’s (VSV) potential for treating prostate cancer. Associate Professor Maureen Ferran from the Thomas H. Gosnell School of Life Sciences secured a three-year, $451,718 Research Enhancement Award (R15) grant from the NIH to investigate prostate cancer cells’ susceptibility to the virus.
-
January 19, 2022
CORBEVAX, a new patent-free COVID-19 vaccine, could be a pandemic game changer globally
Essay by Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, published by The Conversation.
-
December 24, 2021
On a yacht off St. Barts, the future of covid testing is taking shape
The Washington Post talks to Jennifer Schneider, professor and Eugene H. Fram Chair of Applied Critical Thinking, and Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about technology advances and COVID-19 tests.
-
September 25, 2021
New Johnson & Johnson data shows second shot boosts antibodies and protection against COVID-19 – but one dose is still strong against delta variant
Essay by Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, published by The Conversation.
-
August 27, 2021
Do I need a booster shot if I got the Johnson & Johnson vaccine? A virologist answers 5 questions
The Conversation asks Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about the Johnson & Johnson COVID-19 vaccine. This article was republished by PBS Newshour and the Houston Chronicle, among others.
-
June 20, 2021
The Mix and Match Approach Could Be the Way to Vaccinate Every Country Against Covid-19
KCBS Radio talks to Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about how to speed up the COVID-19 vaccine rollout around the world.
-
June 17, 2021
A mix-and-match approach to COVID-19 vaccines could provide logistical and immunological benefits
Essay by Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, published by The Conversation.
-
March 23, 2021
How good is the AstraZeneca vaccine – and is it really safe? 5 questions answered
The Conversation asks Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about the AstraZeneca COVID-19 vaccine.
-
March 12, 2021
The power of science
Essay by Sophia Maggelakis, dean of the College of Science, published by the Rochester Beacon.
-
March 3, 2021
Comparing The COVID-19 Vaccines
NPR's 1A program talks to Maureen Ferran, associate professor in the Thomas H. Gosnell School of Life Sciences, about how the different COVID-19 vaccines work.